In the present study we demonstrated that the overexpression of sTn led to a decrease in gal-3 cell surface binding sites in cancer cells that leads to an accumulation of gal-3 in the intracellular environment, which can account for the chemotherapeutic resistance observed in ST6GalNAc-I-overexpressing tumor cells. The gene discussed is LGALS3; the disease is cancer.